Oncotelic Therapeutics, Inc.
OTLC· OTC
OTLCOncotelic Therapeutics, Inc.
Filed Aug 13, 2012 · 10-Q · 44 days after period end · 0001193125-12-351750
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $0.00 | — | — |
| Net Income | -$2.27M | -$2.93M | $2.54M |
| EPS Diluted | -$1.65 | -$0.32 | $0.73 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 13, 2012 · 44 d after period end
